Zofran MDL Birth Defect Parties Debate Effect Of Albrecht Preemption Ruling

(June 5, 2019, 8:36 AM EDT) -- BOSTON — Parties in the Zofran birth defect multidistrict litigation on June 3 submitted briefs on the applicability of the U.S. Supreme Court’s recent ruling in Merck Sharp & Dohme v. Albrecht, 587 U.S. ____ (2019) (In Re:  Zofran [Ondansetron] Products Liability Litigation, MDL Docket No. 2657, No. 15-md-2657, D. Mass.)....